Business Economy


AM/NS India to commission two production lines this year

AM/NS India to commission two production lines this year

New Delhi, Jan 19 (UNI) ArcelorMittal Nippon Steel India (AM/NS India), a joint venture between ArcelorMittal and Nippon Steel, on Sunday said that it will commission this year two production lines dedicated to manufacturing advanced automotive steel products.

"Once operational, the production of the two units will substitute imports of high-end steel required by the entire automotive sector, promoting the ‘Atmanirbhar Bharat’ initiative. In addition, all the products will match the quality standards of parent companies—ArcelorMittal and Nippon Steel. Some of the offerings currently available globally will also be manufactured for the first time in India," the company said in a media release.

The new lines—a Continuous Galvanising Line (CGL) and a Continuous Galvanising and Annealing Line (CGAL), embedding the technical know-how of the parent companies—are expected to be fully operational in 2025. These two facilities will be part of the upcoming Cold Rolling Mill 2 (CRM2) complex at its flagship plant in Hazira, Gujarat.

The two units will enable the production of ArcelorMittal as well as Nippon Steel’s licensed products, with strength levels up to 1180 MPa, in both coated and uncoated steel.

The expansion aims to meet the growing demand for high-quality, value-added automotive steel in India, which currently stands at 7.8 million tonnes per annum (MTPA) for flat steel and is projected to grow by 6-7% annually.

Dilip Oommen, Chief Executive Officer of ArcelorMittal Nippon Steel India (AM/NS India), said,“This expansion plays a key role in our strategy to strengthen the country’s steel ecosystem and boost global competitiveness, thereby reinforcing the ‘Atmanirbhar Bharat’ initiative.”

UNI NK ARN

More News

Lupin gets US FDA approval for multiple sclerosis tablet

05 Dec 2025 | 8:43 PM

Chennai, Dec 5 (UNI) Pharmaceutical major Lupin Ltd on Friday announced that it has received tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Siponimod Tablets, 0.25 mg, 1 mg, and 2 mg.
This product would be manufactured at Lupin’s Pithampur facility in India.

see more..

Simone Tata who set up brands like Lakme, Westside passes away At 95

05 Dec 2025 | 7:39 PM

Mumbai, Dec 5 (UNI) Simone Tata, who used to be the Managing Director of cosmetics company Lakmé and a Non-Executive Chairperson of Trent until 2006, passed away in Mumbai on Friday morning, according to an official statement issued by the Tata Group.

see more..

Policybazaar showcases claim successes at ‘Insurance Ka Superhero’ event held in Hyderabad

05 Dec 2025 | 6:26 PM

Hyderabad, Dec 5 (UNI) Policybazaar today hosted the fourth edition of its flagship initiative “Insurance Ka Superhero” in city, reaffirming its commitment to fair, transparent and compassionate claim settlements.

see more..

RBI's 25-bps repo rate cut lifts market mood; Rupee steadies as sectors cheer softer policy path

05 Dec 2025 | 6:01 PM

New Delhi, Dec 5 (UNI) India's economic mood turned visibly brighter on Friday after the Reserve Bank of India (RBI) cut the repo rate by 25 basis points to 5.25 per cent, signalling the beginning of a softer interest-rate phase after months of tight financial conditions.

see more..

Xiaomi launches Redmi 15C 5G in India; company highlights strong comeback and evolving consumer trends

05 Dec 2025 | 5:37 PM

Hyderabad, Dec 5 (UNI) Xiaomi India on Friday launched the Redmi 15C 5G, positioned as a feature-rich smartphone offering a sleek design, a large 17.53 cm immersive display and reliable all-day performance for users balancing work and entertainment.

see more..